Class I · High risk Ongoing
DOXOrubin Hydrochloride Liposome injection
Reason Presence of Particulate matter: Particulate matter identified as glass.
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
What was recalled
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
- Recalling firm
- Hospira Inc.
- NDC code
- 0409-1555-54
- Origin
- IL, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-184-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Star recalls
See all
Class II · Moderate risk Ongoing
cimzia
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing
EPINEPHRINE Injection
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing
Five-Star
Reason Stability Data Does Not Support Expiry Date.
Class III · Low risk Ongoing
Pitavastatin Tablets
Reason Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.